InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

IBN ? Annovis Bio Inc. ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer's disease (AD) ...

Utilising genetic information responsibly allows people to understand the uncertain waters of Alzheimer's with both knowledge and hope; ready to confront challenges together. Here’s why genetic testin ...

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in ...

Listen to episode nine, “Executing Clinical Research in Dementia with Lewy Bodies (DLB)” on the Conversations tab of the Cognition website. This conversation is presented in 3 Chapters: 1) Comparing ...

Late-breaking oral presentation to highlight safety and efficacy of LX1001 across four dose cohorts NEW YORK, Oct. 22, 2024 ...